Delta Wave Power: an Independent Sleep Phenotype or Epiphenomenon?
Overview
Psychiatry
Affiliations
Electroencephalographic (EEG) δ waves during non-rapid eye movement sleep (NREMS) after sleep deprivation are enhanced. That observation eventually led to the use of EEG δ power as a parameter to model process S in the two-process model of sleep. It works remarkably well as a model parameter because it often co-varies with sleep duration and intensity. Nevertheless there is a large volume of literature indicating that EEG δ power is regulated independently of sleep duration. For example, high amplitude EEG δ waves occur in wakefulness after systemic atropine administration or after hyperventilation in children. Human neonates have periods of sleep with an almost flat EEG. Similarly, elderly people have reduced EEG δ power, yet retain substantial NREMS. Rats provided with a cafeteria diet have excess duration of NREMS but simultaneously decreased EEG δ power for days. Mice challenged with influenza virus have excessive EEG δ power and NREMS. In contrast, if mice lacking TNF receptors are infected, they still sleep more but have reduced EEG δ power. Sleep regulatory substances, e.g., IL1, TNF, and GHRH, directly injected unilaterally onto the cortex induce state-dependent ipsilateral enhancement of EEG δ power without changing duration of organism sleep. IL1 given systemically enhances duration of NREMS but reduces EEG δ power in mice. Benzodiazepines enhance NREMS but inhibit EEG δ power. If duration of NREMS is an indicator of prior sleepiness then simultaneous EEG δ power may or may not be a useful index of sleepiness. Finally, most sleep regulatory substances are cerebral vasodilators and blood flow affects EEG δ power. In conclusion, it seems unlikely that a single EEG measure will be reliable as a marker of sleepiness for all conditions.
Abnormal power and spindle wave activity during sleep in young smokers.
Dong Y, Cheng Y, Wang J, Ren Z, Lu Y, Yuan K Front Neurosci. 2025; 19:1534758.
PMID: 40008299 PMC: 11850383. DOI: 10.3389/fnins.2025.1534758.
Chmiel J, Stepien-Slodkowska M J Clin Med. 2025; 14(2).
PMID: 39860557 PMC: 11766307. DOI: 10.3390/jcm14020545.
Miranda N, Oliveira L, Moreira T, Ramirez J, Kalume F, Takakura A iScience. 2024; 27(11):111251.
PMID: 39563887 PMC: 11574806. DOI: 10.1016/j.isci.2024.111251.
Salazar Leon L, Kim L, Sillitoe R Neurotherapeutics. 2024; 21(6):e00467.
PMID: 39448336 PMC: 11585869. DOI: 10.1016/j.neurot.2024.e00467.
Fotiadis P, McKinstry-Wu A, Weinstein S, Cook P, Elliott M, Cieslak M bioRxiv. 2024; .
PMID: 39416182 PMC: 11482825. DOI: 10.1101/2024.10.04.616650.